Relapsing multiple sclerosis (MS) is characterised by episodes of inflammatory demyelination in the central nervous system (CNS). While there is limited capacity for the CNS to remyelinate after each...

Janssen-Sponsored Satellite Symposium at the 37th ECTRIMS 2021 Optimising the treatment of people with multiple sclerosis (MS) using prognostic profiling; the  effects of COVID-19 vaccination on...

A restful night’s sleep is a key element in maintaining health and wellbeing, but perhaps less well appreciated is the complex relationship between sleep and diseases such as epilepsy: sleep...

Perampanel is a broad-spectrum antiepileptic drug (AED) with a novel mechanism of action. It is effective as adjunctive therapy to help control both focal-onset seizures and primary generalised...

A group of epilepsy specialist clinicians gathered to discuss the pharmacological management of focal epilepsy and the potential role of eslicarbazepine acetate (Zebinix). The meeting was organised...

Primary generalised tonic-clonic (PGTC) seizures are the most frequent and disabling seizure type among patientswith idiopathic generalised epilepsy. Uncontrolled seizures are associated with high...

Perampanel is a long-acting novel antiepileptic drug (AED) with a unique mechanism of action targeting the AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor. Perampanel’s...

Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder that can cause non-invasive hamartomatous lesions of any number and size in almost every organ, but are most commonly...